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Abstract 
 
Background: Oral squamous carcinoma is a head and neck cancer, which is one of the types of malignant cancers. Present study 
evaluates the anticancer activity of Aster tataricus (AT) on SCC-9 human oral squamous carcinoma.   
Materials and Methods: Ethanol extract of AT was prepared by a standard procedure of maceration. AT extract was used in different 
concentrations like 10, 20, 40, 80, 160, 320 and 640 µg/ml for the evaluation of its anticancer activity. Effect of AT extract on SCC9 
cells were observed by microscope and cytotoxicity by 3-(4, 5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. 
Moreover, clonogenic assay was used for the estimation of effect of AT extract on colony forming ability of SCC9 cells.  
Result: Result of the study suggested that treatment with AT extract causes cytotoxicity to SCC9 cancerous cells. In addition, AT 
extract treatment reduces clonogenic potential of SCC9 cell and it also inhibits the proliferation of cell significantly (p<0.001) in 
G2/M phase. Conclusion: Thus, given study concludes that AT extract effectively attenuates the growth of SCC-9 cancerous cells by 
the virtue of its cytotoxic and anti clonogenic activity. 
 
Key words: Aster tataricus, 3-(4, 5-Dimethylthiazol-2-Yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay, Human oral squamous 
carcinoma, SCC-9 
 
 
Introduction 
 
Oral squamous carcinoma is the 6
th
 most malignant cancer across the globe (Krishna et al., 2013). Every year around 600000 
cases reported and around 350000 deaths occur due to it. Squamous cell carcinoma is the commonest type of oral cancer (Forman et 
al., 2014).  Head and neck cancer may originate from the different anatomical regions such as larynx, nasopharynx, lip, oropharynx 
and neck cavity. In 70 – 75 % cases of head and neck cancer the commonest cause is tobacco and alcohol (Anantharaman et al., 2013). 
Moreover, other risk factor that causes head and neck cancer is human papilloma virus (HPV) infection, poor oral hygiene, deficiency 
of vitamins and malnutrition (de Camargo Cancela et al., 2010). 
However, there are various treatment options available for head and neck cancer such as radiotherapy, chemotherapy and 
surgery (Qi et al., 2010). Although these therapies possess beneficial effects but some time they cause severe toxicity and thereby 
affect the post treatment life of patient. Moreover, resistance of cancer cell from the therapy emerges new problem, which is required 
to develop an alternate therapy for the management of it (Saraswathy and Gong, 2013).   
Aster tataricus (AT) traditionally used in China last from 2000 years for medicinal purpose. Roots of AS contain the 
chemical constituents like triterpenes and saponins (Dongliang and Yu, 1993). Other reported chemicals that were isolated from roots 
such as epifriedelinol, caffeoylquinic acids, astersaponins, shionone and aster peptides (Yu et al., 2015). Traditionally it has been used 
as antibacterial, antifungal, anticancer and management of chronic bronchitis and tuberculosis (Bown, 1995). Literature suggested that 
root extract of AS possess anti-inflammatory, expectorant and antitussive activity (Yu et al., 2015). Caffeoylquinic acids and 
epifriedelinol possess strong antioxidant and anti-inflammatory (Duke and Ayensu, 1985; Ma et al, 2011; Peluso et al, 1995). Thus, 
the given study evaluates the anti cancer activity of AT on human oral squamous carcinoma.  
 
Material and Methods 
Extraction of plant  
 
Root of AS was procured from local supplier and authenticated from Institute of Medicinal Plant Development, Beijing 
(Specimen No: IMPD/10/2016). Extraction of AS roots was done by maceration. Dried root was powdered and kept it with ethanol for 
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72 hrs. Thereafter ethanol was evaporated from the extract at low temperature by rota vapor apparatus. Percentage yield of extract was 
found to be 8.2 % w/w.    
 
Cell and culture media 
 
SCC-9 and NIH/3T3 cell lines were procured from Shanghai Institutes for Biological Sciences, Shanghai, China and all the 
protocols were approved from Ethics Committee of the 306th Hospital of PLA, China. In a 5% CO2 humidified incubator at 37 °C 
cells lines were incubated. DMEM medium was used with (10% v/v) fetal bovine serum as a culture medium for the present study. 
Medium used in this study was replaced at a specific interval of time and cell were trypsinized routenly till it grows up to 80-90% of 
confluency. 
 
Aster tataricus extract treatment 
 
Extract of AT used for the treatment after diluted in the culture medium to achieve serial concentrations. Culture media with 
1% DMSO was used to treat control cells.  
 
Evaluation of morphology of SCC-9 cell lines 
 
Light microscope was used to observe the changes of SCC-9 cells morphology after the treatment with AT extract. Cell lines 
(5 × 10
4
 cells/well) were kept in 96 well plate and for one day treated with AT extract with different concentrations of 0 to 640 µg/ml. 
Moreover, as an additional control fibroblast cells (NIH/3T3) of mouse embryo was used in this study. Morphological changes in the 
cell line were monitored by the help of phase contrast microscope. 
 
Estimation of cell viability by MTT assay 
 
MTT assay was used to assess cellular viability. In which cell (5×10
3
 cells/well) were placed at 96 well plate and treated with 
AT extract at a different concentration for the period of the duration of 3 days. MTT assay was performed as described by Xiao et al. 
MTT (50µl) was added to the well plate and keep it for incubation for 4 hr. at 37˚C. Thereafter from the reaction mixture supernatant 
was washed out and subsequently dimethylsulfoxide (200µl) was added to all the well plate at room temperature. The absorbance was 
estimated at 570 nm wavelength (Xiao et al, 2015).  
 
Estimation of AT extract effect on stages of SCC-9 cell cycle  
 
SCC-9 cells (1×10
6
 cells/well) were seeded in a 6 well plate and incubated for 32 hr. After a specific period of incubation 
DMEM media was replaced by serum (1%) and incubated it for synchronization of cell cycle. These cells were treated with 10, 20, 40, 
80, 160, 320 and 640 µg/ml of AT extract for 24 hr and thereafter PBS was used to wash all the cells, later 70% ethanol at 4º C was 
used to fix it for 24 hr. Later cells were washed and incubated with DNase free-RNase-A (100 µg/ ml) for one hour at 37ºC and 
propidium iodide was used for the staining of it. Cell cycle was estimated by using flowcytometer (Becton Dickinson, USA) (Chen et 
al., 2012). 
 
Clonogenic assay  
 
cells were (5×10
3
 cells/ well) poured in to a 6 well plate and incubated for one day at 37 ºC. These cells were treated with AT 
extract at 50, 100, 200 and 400 µg/ml for one day. Thereafter culture media was exchanged by DMEM containing FBS (10%) and this 
process of replacement of media with fresh one repeated after 5 day. On 21
st
 day cells were washed with PBS and crystal violet 
(0.25%) was used for staining for 30 min. Number of colonies were counted by stereomicroscope and its plating efficiency was 
determined (Franken et al., 2006).  
 
Statistical analysis 
 
Data of given manuscript represented as mean ± SD (n=10). All the results were analyzed statistically by one way ANOVA 
and post hoc study by Dunnett. In this study values p<0.05 was considered as significant.  
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Result 
Effect of AT extract on cell morphology 
 
 Figure 1 
The effect of AT extract on morphological characteristics of SCC9 cell line was shown in Fig.1. AT extract treated SCC9 
cells were lost the characteristics as contact between adjacent cell lost and cell shrunken in size. The effect was found in a dose 
dependent manner.      
 
Evaluation of effect of AT extract on cell by MTT assay 
 
Effect of AT extract on SCC9 cells was estimated by MTT assay as shown in Fig.2. It was observed that treatment with AT 
extract inhibit the proliferation of SCC9 cells in a dose dependent manner as at a low concentration (10-40 µg/ml) AT extract inhibit 
the proliferation by below 20%. Whereas at 80 and 160 µg/ml concentration it shows inhibition of proliferation between 20-30% and 
at higher concentration such as 320 and 640 µg/ml AT extract inhibits above 50% proliferation of SCC9 cell.  
 
 
(A) 
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    (B)      (C) 
Figure 2: Cytotoxic effect of AT extract on SCC9 and NIH/3T3 cell by MTT assay. (A) Inhibitory effect of AT extract on SCC9 
cells. (B) Percentage of growth inhibition of SCC9 cells (C) Percentage of growth inhibition of NIH/3T3 cell. 
Values are means ± SD (n=10); *p < 0.05, **p<0.01, ***p<0.001 (vs. Control group) 
 
Effect of AT extract on SCC9 cell by clonogenic assay 
 
Surviving fractions was found to be significantly decreases when SCC9 cells were treated with AT extract for the period of 
one day. This decrease in survival fraction of SCC9 cell with AT extract was found to be in a dose dependent manner as shown in Fig 
3.A. 
Control group of SCC9 cells has shown 100% cloning ability.  Moreover, treatment with AT extract significantly (p<0.001) 
declines the cloning ability of SCC9 cells as compare to control group in a dose dependent manner as shown in Fig. 3B. 
 
    (A)     (B) 
Figure 3: Effect of AT Extract on SCC-9 Cells clonogenic ability. (A) Survival curve (B) Number colonies  
Values are means ± SD (n=10); *p < 0.05, **p<0.01 (vs. Control group) 
 
Effect of AT extract on SCC9 cell cycle 
 
Effect of AT extract on SCC9 cells at various stages of cell cycle was shown in Fig.4. It was observed that treatment with AT 
extract significantly (p<0.001) increases the cells at G2/M phase compared to control group. Whereas, the cell in G0/G1 phase 
decreases in AT extract treated group compared to control group. 
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Figure 4: Effect of AT extract on SCC9 cells at various stages of cell cycle 
Values are means ± SD (n=10); ***p<0.001 (vs. Control group) 
 
Discussion 
 
Management of cancer becomes complex as due to resistance of cancer cell towards conventional treatment options. 
Literature reveals that phytomedicine possess strong anticancer activity and promises alternative therapy for the management of 
cancer (Xavier et al., 2009). This study evaluates the anticancer activity of Aster tataricus extract on SCC-9 cancer cells.  Effect of AT 
extract on SCC9 cancer cells was evaluated by observing the morphology, MTT assay, clonogenic assay and cells in which phase of  
 
 
cell cycle.  Previous report suggested that phytomedicine do the morphological changes in oral cancer cell line and the result 
of the give study shows that treatment with AT extract causes similar changes in the morphology of SCC9 cell line (King et al., 2007). 
Report suggested that AT contain several chemically active substances that possess several medical properties. Caffeoylquinic acid is 
the chemically active compound that reported to have strong antioxidant and anti-inflammatory property (Duke and Ayensu, 1985; Ma 
et al, 2011; Peluso et al, 1995). Moreover, it has effect on cell viability and effective against lung cancer (In et al, 2016). Thus, 
cytotoxic potential of AT extract was estimated by MTT assay. In which mitochondrial dehydrogenase that is present only in viable 
cell reduces tetrazolium salt and converted it in to formazan (Mosmann, 1983). Our study shows the reduction of tetrazolim salt in a 
dose dependent manner in AT extract treated SCC9 cell line. Moreover, clonogenic ability of cancer cell is the important 
characteristics and estimation of it was dose by clonogenic assay (Katz et al., 2008). Cytotoxic drugs show anticlonogenic activity and 
thereby inhibit the growth of tumor cell. Result of this study suggests that treatment with AT extract significantly (p<0.01) decreases 
cloning ability of SCC9 cells in a dose dependent manner.  In addition, effect of AT extract was observed over the cell cycle and 
observed that treatment with AT extract significantly (p<0.01) increases the no cells in G2/M phase compared to control group.  
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 Conclusion 
 
This study concludes that Aster tataricus extract possess anticancer activity on human oral squamous carcinoma cell line. 
 
References 
 
1. Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, Carreira C, McKay-Chopin S, Gaborieau V, Marron M, Lagiou P, 
Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Talamini R, Simonato L, Castellsague X, Macfarlane TV, Biggs AM, Thakker 
N, Znaor A, Thomson P, Canova C, Conway DI, Healy CM, Tommasino M, Pawlita M, Brennan P (2013). Human 
papillomavirus infections and upperaero-digestive tract cancers: the ARCAGE study. J Natl Cancer Inst, 105: 536-45. 
Rwang et al., Afr J Tradit Complement Altern Med. (2017) 14(2):142-147 
doi:10.21010/ajtcam.v14i2.15 
147 
 
2. Bown. D. Encyclopaedia of Herbs and their Uses. Dorling Kindersley, London. 1995 ISBN 0-7513-020-31. 
3. Chen M, Huang J, Yang X, Liu B, Zhang W, Huang L, Deng F, Ma J, Bai Y, Lu R, Huang B, Gao Q, Zhuo Y, Ge J (2012). 
Serum starvation induced cell cycle synchronization facilitates human somatic cells reprogramming. PLoS One, 7: 28203. 
4. de Camargo Cancela M, Voti L, Guerra-Yi M, Chapuis F, Mazuir M, Curado MP (2010). Oral cavity cancer in developed and in 
developing countries: population-based incidence. Head Neck, 32: 357-67. 
5. Dongliang C., Yu S., (1993). Terpenoid glycosides from the roots of Aster tataricus. Phytochemistry, 35(1): 173-176. 
6. Duke. J. A. and Ayensu. E. S. Medicinal Plants of China Reference Publications, Inc. 1985 ISBN 0-917256-20-4. 
7. Edited by D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Piñeros, E. 
8. Steliarova-Foucher, R. Swaminathan and J. Ferlay (2006). Clonogenic assay of cells in vitro. Nat Protoc, 1:2315-9. 
9. Franken NA, Rodermond HM, Stap J, (2006). Clonogenic assay of cells in vitro. Nat Protoc, 1: 2315-9. 
10. In JK, Kim JK, Oh JS, Seo DW. (2016). 5-Caffeoylquinic acid inhibits invasion of non-small cell lung cancer cells through the 
inactivation of p70S6K and Akt activity: Involvement of p53 in differential regulation of signaling pathways. Int J Oncol. 
48(5):1907-12.  
11. Katz D, Ito E, Lau KS, Mocanu JD, Bastianutto C, Schimmer AD, Liu FF (2008). Increased efficiency for performing colony 
formation assays in 96-well plates: novel applications to combination therapies and high-throughput screening. Biotechniques, 44: 
ix-xiv. 
12. Michael K, Kourt C, Dustin F, Dayne J, Jason P, Aaron S, Susan O, Karl K (2007). Oral squamous cell carcinoma proliferative 
phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement 
Altern Med, 7:22. 
13. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R (2013). Epidemiology of oral cancer in Asia in the past decade--an 
update (2000-2012). Asian Pac J Cancer Prev, 14: 5567-77 
14. Ma C, Dastmalchi K, Whitaker BD, Kennelly EJ. (2011). Two new antioxidant malonated caffeoylquinic acid isomers in fruits of 
wild eggplant relatives. J Agric Food Chem. 59(17): 9645-51. 
15. Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. 
J Immunol Methods, 65: 55-63. 
16. Peluso G, De Feo V, De Simone F, Bresciano E, Vuotto ML., (1995). Studies on the inhibitory effects of caffeoylquinic acids on 
monocyte migration and superoxide ion production. J Nat Prod.  58(5): 639-46. 
17. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W (2010). Chinese herbal medicines as adjuvant treatment during 
chemo- or 
18. radio-therapy for cancer. Biosci Trends, 4: 297-307. 
19. Saraswathy M, Gong S (2013). Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv, 31: 1397- 407. 
20. Xavier CP, Lima CF, Preto A, Seruca R, Fernandes-Ferreira M, Pereira-Wilson C  (2009). Luteolin, quercetin and ursolic acid are 
potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells. 
Cancer Lett, 281: 162-70. 
21. Xiao J, Liu L, Zhong Z, Xiao C and Zhang J., (2015). Mangiferin regulates proliferation and apoptosis in glioma cells by 
induction of microRNA-15b and inhibition of MMP-9 expression. Oncology Reports., 33: 2815-2820. 
22. Yu P, Cheng S, Xiang J, Yu B, Zhang M, Zhang C, Xu X., (2015). Expectorant, antitussive, anti-inflammatory activities and 
compositional analysis of Aster tataricus. J Ethnopharmacol 164: 328-33. 
